Hyperinsulinaemia and Alzheimer's disease.

Hyperinsulinaemia and Alzheimer's disease.

Because the aetiology of Alzheimer's disease (AD) remains unclear, and fasting hyperinsulinaemia has been incriminated in several human diseases, we examined the relationship between AD, fasting plasma insulin, glucose, body mass index and waist: hip ratio in 24 men and 24 women aged 58-90 year...

Podrobná bibliografie
Hlavní autoři:	Razay, G, Wilcock, G
Médium:	Journal article
Jazyk:	English
Vydáno:	1994

Podobné jednotky

Galantamine in Alzheimer's disease.
Autor: Razay, G, a další
Vydáno: (2008)

The metabolic syndrome and Alzheimer disease.
Autor: Razay, G, a další
Vydáno: (2007)

Obesity, abdominal obesity and Alzheimer disease.
Autor: Razay, G, a další
Vydáno: (2006)

Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case-control study
Autor: Razay, G, a další
Vydáno: (2011)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
Autor: Wilcock, G, a další
Vydáno: (1993)

Determining a diagnostic algorithm for hyperinsulinaemia
Autor: Catherine A.P. Crofts, a další
Vydáno: (2019-06-01)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
Autor: Razay, G, a další
Vydáno: (2009)

Hyperinsulinaemia in pregnancy and gestational outcomes: A case series
Autor: Sylvia M. North, a další
Vydáno: (2022-07-01)

Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
Autor: Michelle L. Maugham, a další
Vydáno: (2017-03-01)

Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
Autor: Nadine Monteiro, a další
Vydáno: (2013-01-01)

Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
Autor: Leanne Hodson, a další
Vydáno: (2019-10-01)

Hyperinsulinaemia down-regulates TLR4 expression in the mammalian heart
Autor: Melody ede Laat, a další
Vydáno: (2014-07-01)

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?
Autor: Lynda Guildford, a další
Vydáno: (2020-05-01)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
Autor: Arturo Hernández-Yero, a další
Vydáno: (2012-01-01)

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas
Autor: Isabella D. Cooper, a další
Vydáno: (2021-09-01)

Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
Autor: J. Bashir, a další
Vydáno: (2022-06-01)

Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome
Autor: Rashmi Bhushan, a další
Vydáno: (2022-01-01)

Body iron status and association with hyperinsulinaemia and hyperandrogenism in non-obese Indian women with polycystic ovarian syndrome
Autor: P. Supriya, a další
Vydáno: (2012-01-01)

Treatment for Alzheimer's disease.
Autor: Wilcock, G
Vydáno: (2000)

Neurotrophins in Alzheimer's disease
Autor: Wilcock, G
Vydáno: (2002)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
Autor: Wilcock, G
Vydáno: (1990)

Alzheimer's disease--current issues.
Autor: Wilcock, G
Vydáno: (1988)

Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis
Autor: Martin Sillence, a další
Vydáno: (2022-01-01)

Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses.
Autor: Samira Rahnama, a další
Vydáno: (2020-01-01)

Endothelial cell apoptosis in brown adipose tissue of rats induced by hyperinsulinaemia: the possible role of TNF-α
Autor: M. Markelic, a další
Vydáno: (2011-11-01)

Hypothyroidism in utero stimulates pancreatic beta cell proliferation and hyperinsulinaemia in the ovine fetus during late gestation
Autor: Harris, S, a další
Vydáno: (2017)

Treatment of the cholinergic impairment in Alzheimer's disease
Autor: Wilcock, G
Vydáno: (1994)

Age and Alzheimer's disease.
Autor: Wilcock, G, a další
Vydáno: (1983)

Treating Alzheimer's disease.
Autor: Wilcock, G, a další
Vydáno: (1995)

Velnacrine for Alzheimer's disease.
Autor: Birks, J, a další
Vydáno: (2004)

Current approaches to the treatment of Alzheimer's disease.
Autor: Wilcock, G
Vydáno: (1996)

Bapineuzumab in Alzheimer's disease: where now?
Autor: Wilcock, G
Vydáno: (2010)

Effectiveness of SMS 201-995, a synthetic, long-acting somatostatin analogue, in treatment of quinine-induced hyperinsulinaemia.
Autor: Phillips, R, a další
Vydáno: (1986)

Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
Autor: Erika Harno, a další
Vydáno: (2021-07-01)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
Autor: Wilcock, G
Vydáno: (1994)

Asymmetry of pathology in Alzheimer's disease.
Autor: Wilcock, G, a další
Vydáno: (1987)

The olfactory bulbs in Alzheimer's disease.
Autor: Esiri, M, a další
Vydáno: (1984)

The increasing burden of Alzheimer disease.
Autor: Sadik, K, a další
Vydáno: (2003)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
Autor: Wilcock, G
Vydáno: (1994)

The challenge of Alzheimer's disease--no longer a silent epidemic.
Autor: Wilcock, G
Vydáno: (1988)